Renal Medullary Carcinoma: A Case Report and Brief Review of the Literature

Por Shetty, Aditya, Matrana, Marc R.
Publicado em 2014

Screening for Prostate Cancer: The Debate Continues

Por Matrana, Marc R., Atkinson, Bradley
Publicado em 2013

Building a Phase 1 Cancer Research Program: Lessons Learned and Progress Made

Por Matrana, Marc R., Cook, Julia
Publicado no Ochsner J (2017)

Precision Medicine and the Institutional Review Board: Ethics and the Genome

Por Matrana, Marc R., Campbell, Bob
Publicado no Ochsner J (2020)

Epidemiology and Pathophysiology of Diverticular Disease

Por Matrana, Marc R., Margolin, David A.
Publicado em 2009

Primary Undifferentiated Pleomorphic Sarcoma of the Penis

Por Yoo, Hyung Sun, Satti, Suma, Matrana, Marc
Publicado no Ochsner J (2017)

Outcomes of Patients With Late-Relapse Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: A Single Institution Experience

Por Kucharczyk, John, Mandalapu, Kamal, Satti, Suma, Matrana, Marc R.
Publicado no Ochsner J (2017)

Systemic Therapy for Metastatic Non-Clear Cell Renal Cell Carcinoma: Recent Progress and Future Directions

Por Chowdhury, Simon, Matrana, Marc, Tsang, Christopher, Atkinson, Bradley, Choueiri, Toni K., Tannir, Nizar M.
Publicado em 2011

Neuroendocrine Tumors of the Kidney: A Single Institution Experience

Por Teegavarapu, Purnima Sravanti, Rao, Priya, Matrana, Marc, Cauley, Diana H., Wood, Christopher G, Tannir, Nizar M.
Publicado no Clin Genitourin Cancer (2014)

Outcomes of Patients With Metastatic Renal Cell Carcinoma and End-Stage Renal Disease Receiving Dialysis and Targeted Therapies: A Single Institution Experience

Por Shetty, Aditya V., Matrana, Marc R., Atkinson, Bradley J., Flaherty, Amber L., Jonasch, Eric, Tannir, Nizar M.
Publicado em 2014

Alternative Response Criteria and Clinical Risk Factors for Assessing Tumor Response in Patients With Metastatic Renal Cell Carcinoma Who Are Receiving Salvage Therapy

Por Kang, Hyunseon C., Gupta, Shiva, Wei, Wei, Lu, Lina, Matrana, Marc R., Tannir, Nizar M., Choi, Haesun
Publicado no AJR Am J Roentgenol (2017)

Outcomes of Adults with Ewing’s Sarcoma Family of Tumors (ESFT) of the Kidney: A Single Institution Experience

Por Teegavarapu, Purnima Sravanti, Rao, Priya, Matrana, Marc R., Cauley, Diana H., Wood, Christopher, Patel, Shreyaskumar, Tannir, Nizar M.
Publicado no Am J Clin Oncol (2017)

Outcomes of Unselected Patients with Metastatic Clear-Cell Renal Cell Carcinoma Treated with Front-Line Pazopanib Therapy Followed by Vascular Endothelial Growth Factor Receptor Ty...

Por Matrana, Marc R., Bathala, Tharakeswara, Campbell, Matthew T, Duran, Cihan, Shetty, Aditya, Teegavarapu, Purnima, Kalra, Sarathi, Xiao, Lianchun, Atkinson, Bradley, Corn, Paul, Jonasch, Eric, Tannir, Nizar M
Publicado no BJU Int (2015)

Gemcitabine/nab-paclitaxel with pamrevlumab: a novel drug combination and trial design for the treatment of locally advanced pancreatic cancer

Por Picozzi, Vincent, Alseidi, Adnan, Winter, Jordan, Pishvaian, Michael, Mody, Kabir, Glaspy, John, Larson, Timothy, Matrana, Marc, Carney, Mairead, Porter, Seth, Kouchakji, Elias, Rocha, Flavio, Carrier, Ewa
Publicado no ESMO Open (2020)

Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases

Por Kalra, Sarathi, Atkinson, Bradley J., Matrana, Marc Ryan, Matin, Surena F., Wood, Christopher G., Karam, Jose A., Tamboli, Pheroze, Sircar, Kanishka, Rao, Priya, Corn, Paul Gettys, Tannir, Nizar M., Jonasch, Eric
Publicado no BJU Int (2015)

nab-Paclitaxel–Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2

Por Gajra, Ajeet, Karim, Nagla Abdel, Mulford, Deborah A., Villaruz, Liza Cosca, Matrana, Marc Ryan, Ali, Haythem Y., Santos, Edgardo S., Berry, Tymara, Ong, Teng Jin, Sanford, Alexandra, Amiri, Katayoun, Spigel, David R.
Publicado no Front Oncol (2018)

A patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasis

Por Gills, Jessie, Moret, Ravan, Zhang, Xin, Nelson, John, Maresh, Grace, Hellmers, Linh, Canter, Daniel, Hudson, M’Liss, Halat, Shams, Matrana, Marc, Marino, Michael P., Reiser, Jakob, Shuh, Maureen, Laborde, Eric, Latsis, Maria, Talwar, Sunil, Bardot, Stephen, Li, Li
Publicado no Oncotarget (2018)

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Non-Pancreatic Neuroendocrine Tumors

Por Patel, Sandip Pravin, Othus, Megan, Chae, Young Kwang, Giles, Francis, Hansel, Donna E., Singh, Preet P., Fontaine, Annette C., Shah, Manisha, Kasi, Anup, Baghdadi, Tareq Al, Matrana, Marc R., Gatalica, Zoran, Korn, W. Michael, Hayward, Jourdain, McLeod, Christine M., Chen, Helen X., Sharon, Elad, Mayerson, Edward, Ryan, Christopher W., Plets, Melissa, Blanke, Charles D., Kurzrock, Razelle
Publicado no Clin Cancer Res (2020)

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors

Por Santoni, Matteo, Heng, Daniel Y., Bracarda, Sergio, Procopio, Giuseppe, Milella, Michele, Porta, Camillo, Matrana, Marc R., Cartenì, Giacomo, Crabb, Simon J., De Giorgi, Ugo, Basso, Umberto, Masini, Cristina, Calabrò, Fabio, Vitale, Maria Giuseppa, Santini, Daniele, Massari, Francesco, Galli, Luca, Fornarini, Giuseppe, Ricotta, Riccardo, Buti, Sebastiano, Zucali, Paolo, Caffo, Orazio, Morelli, Franco, Carrozza, Francesco, Martignetti, Angelo, Gelibter, Alain, Iacovelli, Roberto, Mosca, Alessandra, Atzori, Francesco, Vau, Nuno, Incorvaia, Lorena, Ortega, Cinzia, Scarpelli, Marina, Lopez-Beltran, Antonio, Cheng, Liang, Paolucci, Vittorio, Graham, Jeffrey, Pierce, Erin, Scagliarini, Sarah, Sepe, Pierangela, Verzoni, Elena, Merler, Sara, Rizzo, Mimma, Sorgentoni, Giulia, Conti, Alessandro, Piva, Francesco, Cimadamore, Alessia, Montironi, Rodolfo, Battelli, Nicola
Publicado no Cancers (Basel) (2019)